DAILY MORNING NOTE | 12 October 2023

Local shares fell on Wednesday (Oct 11) as trader behaviour in the stock markets reflected cautious sentiments. This contrasted with the regional rally, which came after reports of a dovish shift in tone from US Federal Reserve officials on interest rate hikes. Nio was Wednesday’s top gainer. The stock added 3.7 per cent or US$0.31 to close at US$8.80. Jardine Matheson Holdings was the day’s biggest loser, shedding 5.1 per cent or US$2.31 to US$42.92. Among the trio of local banks, DBS lost 0.7 per cent or S$0.25 to S$33.72, and UOB fell 0.2 per cent or S$0.06 to S$28.50. OCBC, meanwhile, closed flat at S$13.00.

Wall Street stocks closed higher on Wednesday as traders await key US consumer inflation data, while shrugging off hotter than expected wholesale price increases. The Dow Jones Industrial Average closed 0.2 per cent up at 33,804.87. The broad-based S&P 500 rose 0.4 per cent to 4,376.95, while the tech-rich Nasdaq Composite Index gained 0.7 per cent to 13,659.68. Minutes from the most recent Fed policy meeting showed on Wednesday that officials agreed to hold rates high “for some time” until confident that inflation is cooling sustainably.

Top gainers & losers





Creative Technology has given notice that it has recorded pre-tax losses for three consecutive years. It however meets the financial entry criteria to avoid being placed on the Singapore Exchange’s (SGX) watch list, as its six-month average daily market capitalisation as at Wednesday (Oct 11) was S$110.3 million. According to SGX listing rules, mainboard-listed companies will be placed on the watch list under the financial entry criteria if they record pre-tax losses for the three most recently completed consecutive financial years, and fail to maintain an average daily market cap of at least S$40 million over the last six months. Companies on the watch list must take active steps to satisfy the financial requirements within 36 months from the date they are placed on the list. That means recording a consolidated pre-tax profit for the most recently completed financial year, based on the latest full-year consolidated audited accounts, and having an average daily market cap of S$40 million or more over the last six months. Otherwise, they will be delisted from the SGX, or have their trading suspended with a view to delisting.

Centurion Corp is likely to be impacted by the Ministry of Manpower in Singapore announcement of a Dormitory Transition Scheme (DTS) for existing dormitories approved or operational before Sept 18 2021 to transition to improved Interim Dormitory Standards (IDS). The aim is to strengthen resilience against future pandemics and enhance liveability. Key interim specifications in the IDS include requirements for a maximum of 12 residents per apartment unit, living space of at least 3.6 sq m per resident, toilets and showers to be ensuite in the apartment units, and more stringent requirements in the isolation facilities of 1% of bed capacity in normal times and additionally 1.5% during a pandemic. Centurion Corp is likely to be impacted by the new regulations. It has already planned for partial redevelopment of two of the PBDs, Westlite Toh Guan and Westlite Mandai, sitting on long leasehold and freehold land respectively. The company received provisional permissions for the redevelopment and plans to substantially complete the added dormitory bed supply ahead of 2027, when the transition period begins.

Thomson Medical Group has appointed Lee Suen Ming as its new chief executive officer, the healthcare group said in a bourse filing on Wednesday (Oct 11). Lee was previously chief executive officer at Mount Alvernia Hospital, Gleneagles Hospital, Parkway East Hospital and most recently, the Dr Soliman Fakeeh Hospital in Saudi Arabia. He will take over from Dr Daniel Lee on Nov 1. Dr Melvin Heng, group chief executive officer of Thomson Medical Group, said Lee Suen Ming’s appointment comes at a “pivotal point in a growth story that we kick-started a year ago”.


Exxon Mobil has agreed to buy Pioneer Natural Resources for US$59.5 billion, its largest takeover in more than two decades, as it seeks to become the dominant producer of shale oil. Exxon will pay US$253 per share in an all-stock deal, according to a statement on Wednesday (Oct 11). The agreement paves the way for Exxon’s biggest acquisition since merging with Mobil Corp in 1999 and is the world’s largest corporate takeover announced this year. The transaction amounts to an 18 per cent premium for Pioneer investors, based on the closing price on Oct 5, when reports of the impending deal began to swirl. If finalised, the combination will make Exxon the biggest player in the Permian Basin of Texas and New Mexico and bring the company’s daily production to nearly 4.5 million barrels of oil equivalent a day – 50 per cent more than the next biggest supermajor. The agreement will allow Exxon to boost daily output in the Permian region to the equivalent of 2 million barrels in 2027, or more than half of the oil titan’s current worldwide production. Exxon also pledged to reduce net-carbon dioxide emissions from Pioneer assets to zero by 2035, or 15 years sooner than originally planned, according to the release.

Printer maker Xerox Holdings on Wednesday (Oct 11) said it had sold its operations in Russia to local management for an undisclosed sum, becoming the latest Western business to cut ties with Russia over its February 2022 invasion of Ukraine. Hundreds of foreign companies have left Russia since Moscow began what it calls a “special military operation” in Ukraine, with some selling up for a nominal fee and others having their assets seized by the Russian state. Russia has steadily tightened exit requirements, now demanding a 50 per cent discount on any sale and a contribution to the Russian budget of at least 10 per cent of the sale price, dubbed an “exit tax” by Washington. Executives say navigating the rules is becoming harder. Russia’s Interfax news agency earlier on Wednesday reported that top managers at the Russian division of Xerox had become its new owners.

The US dollar was broadly flat against major currencies, as traders trained their sights on the release of Federal Reserve minutes later on Wednesday (Oct 11) and a key inflation print the next day for hints on the future path for interest rates. US Treasury yields continued to slide, pinning the US dollar close to two-week lows as markets digest recent comments from policymakers that the Fed may not need to tighten monetary policy further. The benchmark 10-year US Treasury yield dropped ten basis points, extending declines from Tuesday after a sharp sell-off in September left bonds cheap. The US dollar index – which tracks the greenback against six major currencies – edged up 0.1 per cent to 105.82, after dipping earlier in the session to a two-week low of 105.6. The index had closed lower over the previous five trading sessions.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Strategy & Stock Picks (US Market)

Date & Time: 12 Oct 2023 | 7.30pm – 9pm

Register: https://tinyurl.com/ycy2ezwu

Guest Presentation by Keppel Pacific Oak US REIT (KORE)

Date & Time: 19 Oct 2023 | 12pm – 1pm

Register: http://tinyurl.com/5n8kh8ta

Corporate Insights by Sasseur REIT [NEW]

Date & Time: 15 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/464ndms7

POEMS Podcast:

Research Videos

Singapore Equity 4Q23 Strategy
Date: 9 October 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com